An approach to enhancing the phototoxicity of a novel hypocrellin congener to MGC803 cells

Dyes and Pigments

Volumn 51, Issue 2-3, 2001, Pages 103-110

  Yang, Hong Ying ^a   Zhang, Wen Geng ^a   Ma, Li Ping ^b   Wang, Shen Wu ^b   Zhang, Zhi Yi ^a  

^a INSTITUTE OF BIOPHYSICS   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

Hypocrellin congener; MGC803 cells; Photodynamic therapy; Photosensitizer

Indexed keywords

PHOTODYNAMIC THERAPY; PHOTOSENSITIZERS; TOXICITY;

PHOTOTOXICITY;

CELLS;

SURGICAL PRODUCT;

EID: 0035507164     PISSN: 01437208     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0143-7208(01)00059-6     Document Type: Article

References (39)

1. Photodynamic therapy begins to shine
2. Photodynamic therapy expands its horizons
3. Preclinical examination of first and second generation photosensitizers used in photodynamic therapy
4. 2 OH, HB) generated during photosensitization of hypocrellin B
5. Relationship between photosensitizing activities and chemical structure of hypocrellin A and B
6. 2) generated during photoirradiation of hypocrellin A
7. Characteristics of the primary reaction of hypocrellin A photosensitization
8. The reaction between hypocrellin B and ethanolamine
9. Hypocrellin B-ethanolamine (HB-E) sensitized photodamage on rat mitochondrial
10. Photosensitized damage of ethanolamine-HB on murine ascitic hepatoma cells
11. Photosensitizing damage to morphology of HeLa cells by bromide of hypocrellin B (5-Br-HB)
12. Sulphonated hypocrellin B sensitized photodamage to ascitic hepatoma cells
13. A novel photosensitizer, 2-butylamino-2-demethoxy-hypocrellin A (2-BA-2-DMHA), 1. Synthesis of 2-BA-2-DMHA and its phototoxicity to MGC803 cells
14. Increased photosensitivity in HL60 cells expressing wild-type p53
15. The cellular gatekeeper for growth and division
16. Suppression of human colorectal carcinoma cell growth by wild type p53
17. Wild type p53 induces apoptosis in a Burkitt lymphoma (BL) line that carries mutant p53
18. Wild type p53 demonstrates functional dominance in a human colon carcinoma cell line in which it induces reversible growth arrest
19. Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles
20. Wild type p53 induces apoptosis of myeloid leukemic cells that is inhibited by interleukin-6
21. The establishment and biological characteristics of a poorly differentiated human gastric adenocarcinoma MGC803 cell line
22. Improved retroviral vectors for gene transfer and expression
23. Single step method of RNA isolation by acid guanidinium thiocyanate phenol chloroform extraction
24. Photodynamic treatment of human endothelial cells promotes the adherence of neutrophils in vitro
25. p53 tumor suppressor gene therapy for cancer
26. High-efficiency retrovirus-mediated gene transfer into the lives of mice
27. Induction of chemosensitivity in human lung cancer cells in vivo by adenoviral-mediated transfer of the wild-type p53 gene
28. Expression of wild-type p53 increase etoposide cytotoxicity in MI myeloid leukemia cells by facilitated G2 to M transition: Implications for gene therapy
29. Novel combination therapy for human colon cancer with adenovirus-mediated wild-type p53 gene transfer and DNA-damaging chemotherapeutic agent
30. Adenoviral-mediated wild-type p53 gene expression sensitizes colorectal cancer cells to ionizing radiation
31. Adenovirus-based transfer of wild-type p53 gene increases ovarian tumor radiosensitivity
32. Transferrin-liposome-mediated p53 sensitization of squamous cell carcinoma of the head and neck to radiation in vitro
33. Inactivation of p53 increases the cytotoxicity of camptothecin in human colon HCT116 and breast MCF-7 cancer cells
34. p53 mutation does not correlate with radiosensitivity in head and neck and cancer cell lines
35. Concominant p53 gene mutation and increased radiosensitivity in rat lung embryo epitheliat cells during neoplastic development
36. Mitochondrial control of apoptosis
37. Reactive oxygen species are downstream mediators of p53-dependent apoptosis
38. A model for p53-induced apoptosis
39. Apoptosis in cancer therapy: Crossing the threshold